IL-STERN-PINBALL-INC
22.9.2022 16:01:41 CEST | Business Wire | Press release
Stern Pinball, Inc. launches a new line of pinball machines celebrating the iconic, genre-defining James Bond films. The James Bond 007 cornerstone series features the original 007 actor, Sean Connery, available in Pro Edition, Premium Edition, and Limited Edition (LE). Stern Pinball will also release a special James Bond 007 60th Anniversary Limited Edition pinball machine featuring all six James Bond actors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220922005077/en/
James Bond 007 Pinball Pro Edition (Photo: Business Wire)
In Dr. No (1962) Sean Connery propelled 007 into the cultural zeitgeist, bringing the legendary literary figure to life through adrenalized action sequences, ground-breaking gadgets and effects, memorable characters, and timeless villains.
Stern’s James Bond 007 cornerstone pinball machine will highlight film footage and iconic music from the films that built the 007 legend: Dr. No, From Russia With Love (1963), Goldfinger (1964), Thunderball (1965), You Only Live Twice (1967), and Diamonds Are Forever (1971). Players are immersed into the world of espionage in this action-packed pinball experience, tackling assignments, teaming up with key allies, and stopping SPECTRE’s villainous schemes.
Gather gadgets from Q Branch as pinballs get ejected through the roof of a custom sculpted Aston Martin DB5. Break through the Osato Chemicals drop targets to battle SPECTRE at the Bird 1 rocket base. And hold your breath on the gravity defying, magnetic jetpack as it transports pinballs across the playfield.
James Bond 007 pinball machines include Stern’s award-winning Insider Connected™ system, which enables players to interact with the game and a global network of players in a variety of ways. Through Insider Connected, players can track progress, earn new game-specific achievements, engage with the player community, and participate in promotions and Challenge Quests. Insider Connected also provides an operator-focused toolset to drive location play through Location Leaderboards, build player loyalty, analyze performance, make adjustments remotely, and maintain the machines. Registration for Insider Connected is available at insider.sternpinball.com/.
Limited to 1,000 machines globally, the highly collectible cornerstone Limited Edition includes an exclusive full-color mirrored backglass inspired by Thunderball, masterfully adapted cabinet artwork, custom high gloss and powder-coated pinball armor, a custom designer-autographed bottom arch, exclusive inside art blades, upgraded audio system, anti-reflection pinball playfield glass, shaker motor, a sequentially numbered plaque, and a Certificate of Authenticity signed by Stern Chairman Gary Stern and President Seth Davis.
Stern’s James Bond 007 60th Anniversary Limited Edition pinball machines will immerse players in the history of 007. Limited to 500 machines globally, the highly collectible 60th Anniversary Limited Edition offers players a retro-inspired playfield packed with exciting mechanical action. Control the chaos from Oddjob’s kinetic spinning disc hat, survive tactical precision shots against 10 drop targets, escape SPECTRE’s evil henchmen navigating pinballs through 4 fast-flowing optical spinners, learn assignments through an in-playfield LCD screen, and rack up high scores on classic-style score reels.
“James Bond is as timeless as pinball. Partnering with EON Productions/Danjaq, MGM Studios and Aston Martin, we created a pinball adventure capturing the suspense, action, and humor from this beloved film series,” said Gary Stern, Chairman and CEO. “Get connected today and become a legend.”
Fittingly, the new James Bond 007 pinball machines will be on show for the first time to media and public in London. On September 26th the games will be on display and available to play as part of the Bond-themed Christie’s Late, a public event celebrating the forthcoming Christie’s Sixty Years of James Bond Charity Auction. Shortly after, they will be a part of the James Bond at 60 weekend at the British Film Institute on the South Bank, September 30th-October 2nd.
Pricing and Availability:
Manufacturer’s Suggested Retail Price (“MSRP”)*:
*MSRP for sales to USA end-users, before any VAT, GST, Sales Tax, Duties, or other taxes.
Pro Edition: $US 6,999
Premium Edition: $US 9,699
Limited Edition: $US 12,999
60th Anniversary Limited Edition: CALL FOR PRICE
James Bond 007 pinball machines and accessories are available now through authorized Stern Pinball distributors and dealers around the world. Pro and Premium Editions will also be available at 007Store.com.
About Stern Pinball, Inc.
Stern Pinball, Inc. is a global lifestyle brand based on the iconic and outrageously fun modern American game of pinball. Headquartered minutes from Chicago’s O’Hare International Airport in the heart of North America, the company creates, designs, engineers, manufactures, markets, and distributes a full line of technologically advanced terrestrial and digital pinball games, parts, accessories, and merchandise. Stern Pinball serves digital, consumer, commercial, and corporate markets around the globe.
Recent Stern Pinball titles include Rush, Godzilla, The Mandalorian, Led Zeppelin, Avengers: Infinity Quest, Teenage Mutant Ninja Turtles, Stranger Things, Elvira’s House of Horrors, Jurassic Park, Black Knight: Sword of Rage, The Munsters, The Beatles, Deadpool, Iron Maiden, Guardians of the Galaxy, Star Wars, Aerosmith, Ghostbusters, KISS, Metallica, Game of Thrones, The Walking Dead, Star Trek, AC/DC, Batman, and Spider-Man. A broad range of players enjoy Stern Pinball’s games from professional pinball players who compete in high-stakes competitions around the globe to novice players who are discovering the allure of the silver ball for the first time. To join the fun and learn more, please visit www.sternpinball.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005077/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 09:20:00 CEST | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release
STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release
Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria
Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom